Author:
Wu Gang,Zhang Xiaoxi,Wang Xin,Du Jialiang,Li Meng,Xu Gangling,Du Min,Yu Chuanfei
Reference43 articles.
1. Antibody-drug conjugates come of age in oncology;C Dumontet;Nature Reviews Drug Discovery,2023
2. Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia;Pf; Bross;Clinical Cancer Research,2001
3. Strategies and challenges for the next generation of therapeutic antibodies;A; Beck;Nat Rev Immunol,2010
4. Seattle Genetics' Antibody-Drug Conjugate Receives FDA Okay to Treat Lymphomas;Genetic Engineering & Biotechnology News,2011
5. FDA approves new treatment for late-stage breast cancer;Press release). U.S. Food and Drug Administration (FDA)